MICAFUNGIN

MICAFUNGIN was reported 6576 times

MICAFUNGIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS 11 0.8462
1 ANTI FACTOR V ANTIBODY 19 0.6786
2 WEISSELLA INFECTION 7 0.6364
3 PRE-ENGRAFTMENT IMMUNE REACTION 42 0.5250
4 MENINGITIS ASPERGILLUS 4 0.2857
5 PULMONARY TRICHOSPORONOSIS 6 0.2609
6 ENCEPHALITIS JAPANESE B 4 0.2222
7 MINIMUM INHIBITORY CONCENTRATION INCREASED 4 0.2000
8 PARANASAL SINUS MASS 4 0.1818
9 CORYNEBACTERIUM BACTERAEMIA 14 0.1647
10 GEOTRICHUM INFECTION 30 0.1422
11 CEREBRAL VENTRICLE COLLAPSE 10 0.1333
12 GASTROINTESTINAL MUCORMYCOSIS 20 0.1198
13 SCOPULARIOPSIS INFECTION 4 0.0889
14 MYCOTIC ENDOPHTHALMITIS 16 0.0847
15 PULMONARY MUCORMYCOSIS 44 0.0833
16 FLUOROSIS 7 0.0814
17 DISSEMINATED MUCORMYCOSIS 31 0.0787
18 TRICHOSPORON INFECTION 31 0.0765
19 HAEMORRHAGIC NECROTIC PANCREATITIS 5 0.0667
20 RHINOCEREBRAL MUCORMYCOSIS 21 0.0605
21 PERIHEPATIC ABSCESS 5 0.0602
22 FLUORIDE INCREASED 3 0.0566
23 FUSARIUM INFECTION 39 0.0557
24 ENCEPHALITIS FUNGAL 5 0.0556
25 CEREBRAL ASPERGILLOSIS 34 0.0553
26 CRYPTOCOCCAL MENINGOENCEPHALITIS 7 0.0534
27 MENINGITIS ENTEROCOCCAL 4 0.0506
28 FUNGAL ENDOCARDITIS 15 0.0498
29 BILOMA 7 0.0496
30 FUNGAL DISEASE CARRIER 5 0.0495
31 NASAL ABSCESS 11 0.0476
32 IDIOPATHIC PNEUMONIA SYNDROME 14 0.0470
33 SCEDOSPORIUM INFECTION 33 0.0467
34 HYPEROXALURIA 8 0.0465
35 PHAEHYPHOMYCOSIS 6 0.0448
36 BORDETELLA INFECTION 4 0.0444
37 ENCEPHALITIS VIRAL 53 0.0435
38 CAPNOCYTOPHAGA INFECTION 4 0.0426
39 HUMAN HERPESVIRUS 6 ENCEPHALITIS 12 0.0423
40 DISSEMINATED TRICHOSPORONOSIS 3 0.0417
41 INTRAOCULAR PRESSURE TEST 10 0.0417
42 GASTROINTESTINAL FUNGAL INFECTION 21 0.0408
43 BURKHOLDERIA TEST POSITIVE 5 0.0403
44 ENDOCARDITIS CANDIDA 3 0.0395
45 FUNGAEMIA 62 0.0394
46 BACTERIAL TOXAEMIA 5 0.0388
47 DISSEMINATED ASPERGILLOSIS 18 0.0381
48 LACTOBACILLUS INFECTION 6 0.0366
49 BONE MARROW LEUKAEMIC CELL INFILTRATION 3 0.0366
50 MUCORMYCOSIS 95 0.0365
51 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 8 0.0345
52 SYSTEMIC MYCOSIS 40 0.0342
53 CYSTITIS VIRAL 13 0.0339
54 EYE INFECTION FUNGAL 13 0.0336
55 CANDIDA ENDOPHTHALMITIS 4 0.0328
56 HUMAN HERPESVIRUS 6 INFECTION 62 0.0328
57 PERIOSTITIS 14 0.0324
58 STOMATOCOCCAL INFECTION 4 0.0323
59 BACTERIAL TRANSLOCATION 10 0.0315
60 OSTEOMYELITIS FUNGAL 5 0.0299
61 SINUSITIS FUNGAL 24 0.0299
62 STENOTROPHOMONAS TEST POSITIVE 4 0.0299
63 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 5 0.0289
64 SYSTEMIC CANDIDA 71 0.0283
65 BACILLUS BACTERAEMIA 3 0.0275
66 HEPATOSPLENIC CANDIDIASIS 4 0.0272
67 SUBACUTE HEPATIC FAILURE 4 0.0268
68 PLASMA CELL LEUKAEMIA 16 0.0267
69 BLOOD BETA-D-GLUCAN INCREASED 8 0.0261
70 SINUS POLYP 15 0.0260
71 ENTEROCOCCAL SEPSIS 21 0.0259
72 FACTOR V INHIBITION 5 0.0258
73 PYROGLUTAMIC ACIDOSIS 10 0.0252
74 DISSEMINATED CRYPTOCOCCOSIS 19 0.0251
75 CEREBRAL FUNGAL INFECTION 7 0.0247
76 ALTERNARIA INFECTION 9 0.0242
77 CANDIDA TEST POSITIVE 10 0.0239
78 GLOMERULOSCLEROSIS 15 0.0237
79 ZYGOMYCOSIS 11 0.0235
80 HAEMOPHILUS TEST POSITIVE 3 0.0233
81 ASPERGILLUS INFECTION 151 0.0230
82 ABSCESS FUNGAL 4 0.0229
83 BRONCHIOLITIS OBLITERANS SYNDROME 4 0.0229
84 GASTROINTESTINAL MUCOSAL EXFOLIATION 3 0.0226
85 LEUKOSTASIS SYNDROME 3 0.0226
86 MENINGOENCEPHALITIS HERPETIC 10 0.0223
87 NASAL FLARING 3 0.0222
88 PANOPHTHALMITIS 4 0.0219
89 ENTEROCOCCAL BACTERAEMIA 23 0.0217
90 ALKALOSIS HYPOCHLORAEMIC 3 0.0214
91 DISSEMINATED COCCIDIOIDOMYCOSIS 3 0.0213
92 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 30 0.0212
93 CRYPTOCOCCAL FUNGAEMIA 3 0.0210
94 OPHTHALMIC VEIN THROMBOSIS 5 0.0207
95 BANDAEMIA 3 0.0204
96 INFECTIVE ANEURYSM 10 0.0202
97 MUCOSAL EROSION 18 0.0198
98 ASPERGILLUS TEST POSITIVE 6 0.0195
99 ADENOVIRAL HAEMORRHAGIC CYSTITIS 4 0.0192
100 MUCOSAL NECROSIS 3 0.0191
101 CRYPTOSPORIDIOSIS INFECTION 10 0.0190
102 HEPATIC VEIN OCCLUSION 3 0.0190
103 ALLOGENIC STEM CELL TRANSPLANTATION 3 0.0190
104 HUMAN POLYOMAVIRUS INFECTION 10 0.0188
105 CITROBACTER INFECTION 8 0.0186
106 ENTEROCOCCUS TEST POSITIVE 12 0.0185
107 ENCEPHALITIS HERPES 9 0.0182
108 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 13 0.0181
109 PNEUMONIA FUNGAL 70 0.0177
110 BRONCHOPULMONARY ASPERGILLOSIS 137 0.0177
111 FUNGAL OESOPHAGITIS 12 0.0170
112 GRAFT VERSUS HOST DISEASE IN LIVER 12 0.0168
113 GRAFT VERSUS HOST DISEASE IN LUNG 8 0.0167
114 CUTANEOUS MUCORMYCOSIS 3 0.0163
115 ACINETOBACTER BACTERAEMIA 3 0.0160
116 DYSBIOSIS 13 0.0158
117 CAVERNOUS SINUS THROMBOSIS 4 0.0157
118 FUNGAL SEPSIS 13 0.0156
119 TRACHEOBRONCHITIS 12 0.0156
120 MEDIASTINITIS 9 0.0155
121 GRANULOCYTOSIS 3 0.0153
122 ECTHYMA 6 0.0150
123 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 6 0.0148
124 KLEBSIELLA BACTERAEMIA 14 0.0147
125 BACTERIAL SEPSIS 47 0.0144
126 CYTOMEGALOVIRUS ENTEROCOLITIS 11 0.0143
127 BACTERIURIA 8 0.0142
128 PULMONARY MYCOSIS 11 0.0141
129 STENOTROPHOMONAS INFECTION 19 0.0140
130 GASTROINTESTINAL MUCOSAL DISORDER 9 0.0137
131 SEPTIC EMBOLUS 11 0.0132
132 GRAFT VERSUS HOST DISEASE IN EYE 3 0.0130
133 DEVICE RELATED SEPSIS 26 0.0129
134 BRONCHIAL HAEMORRHAGE 4 0.0128
135 ADENOVIRAL HEPATITIS 3 0.0128
136 INFECTION IN AN IMMUNOCOMPROMISED HOST 9 0.0125
137 ENTEROBACTER INFECTION 21 0.0125
138 CAT SCRATCH DISEASE 5 0.0124
139 ENTEROCOCCAL INFECTION 60 0.0124
140 NECROTISING OESOPHAGITIS 6 0.0120
141 ENTEROVIRUS INFECTION 10 0.0116
142 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 32 0.0116
143 KLEBSIELLA INFECTION 58 0.0115
144 DELAYED GRAFT FUNCTION 8 0.0113
145 HAEMOSIDEROSIS 3 0.0112
146 BRAIN ABSCESS 28 0.0111
147 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 4 0.0110
148 CHOLESTATIC LIVER INJURY 24 0.0108
149 VANCOMYCIN INFUSION REACTION 4 0.0106
150 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 4 0.0105
151 BURKHOLDERIA CEPACIA COMPLEX INFECTION 3 0.0105
152 ACUTE GRAFT VERSUS HOST DISEASE 48 0.0105
153 LEISHMANIASIS 3 0.0103
154 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 22 0.0103
155 BLASTOMYCOSIS 5 0.0103
156 LOWER RESPIRATORY TRACT INFECTION FUNGAL 4 0.0103
157 NEUTROPENIC COLITIS 21 0.0101
158 GRAFT VERSUS HOST DISEASE IN SKIN 22 0.0100
159 VIRAL HAEMORRHAGIC CYSTITIS 7 0.0098
160 INFECTIVE EXACERBATION OF BRONCHIECTASIS 3 0.0098
161 VASOGENIC CEREBRAL OEDEMA 7 0.0097
162 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 3 0.0097
163 BOTULISM 8 0.0097
164 BACILLUS INFECTION 6 0.0095
165 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 31 0.0094
166 CORYNEBACTERIUM INFECTION 5 0.0093
167 PNEUMONIA KLEBSIELLA 17 0.0092
168 PULMONARY CAVITATION 8 0.0092
169 OBLITERATIVE BRONCHIOLITIS 12 0.0091
170 CANDIDA INFECTION 154 0.0091
171 OESOPHAGEAL INFECTION 4 0.0089
172 METAPNEUMOVIRUS INFECTION 7 0.0089
173 VENOOCCLUSIVE LIVER DISEASE 43 0.0087
174 KIDNEY FIBROSIS 15 0.0086
175 MULTIPLE ORGAN DYSFUNCTION SYNDROME 244 0.0086
176 JOINT ABSCESS 3 0.0086
177 ESCHERICHIA BACTERAEMIA 20 0.0085
178 POLYOMAVIRUS VIRAEMIA 9 0.0085
179 ENGRAFTMENT SYNDROME 5 0.0085
180 ASPERGILLOSIS 11 0.0084
181 PROTEUS INFECTION 6 0.0084
182 TOXOPLASMOSIS 9 0.0083
183 DIFFERENTIATION SYNDROME 6 0.0082
184 HAEMOPHILUS INFECTION 8 0.0082
185 VASCULAR DEVICE INFECTION 37 0.0081
186 HUMORAL IMMUNE DEFECT 3 0.0081
187 PSEUDOMONAL SEPSIS 14 0.0080
188 PHARYNGEAL ABSCESS 4 0.0080
189 HEPATIC INFARCTION 3 0.0080
190 ESCHERICHIA SEPSIS 23 0.0079
191 STAPHYLOCOCCAL BACTERAEMIA 34 0.0078
192 CANDIDA SEPSIS 7 0.0078
193 PNEUMONIA NECROTISING 5 0.0077
194 VARICELLA ZOSTER VIRUS INFECTION 16 0.0077
195 MYCOPLASMA INFECTION 6 0.0077
196 GRAFT VERSUS HOST DISEASE 55 0.0076
197 CENTRAL NERVOUS SYSTEM LEUKAEMIA 3 0.0076
198 ENDOCARDITIS BACTERIAL 6 0.0076
199 ACUTE MYELOID LEUKAEMIA RECURRENT 16 0.0074
200 RENAL ABSCESS 6 0.0073
201 ACINETOBACTER INFECTION 8 0.0073
202 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 53 0.0071
203 PATHOGEN RESISTANCE 64 0.0070
204 CENTRAL NERVOUS SYSTEM INFECTION 8 0.0070
205 DIFFUSE ALVEOLAR DAMAGE 8 0.0070
206 ACUTE SINUSITIS 12 0.0070
207 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 8 0.0067
208 LINEAR IGA DISEASE 11 0.0066
209 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 17 0.0066
210 ORAL FUNGAL INFECTION 18 0.0066
211 SKIN NECROSIS 34 0.0065
212 ADENOVIRUS INFECTION 19 0.0065
213 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0065
214 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 3 0.0064
215 CEREBRAL HYPOPERFUSION 3 0.0064
216 LUNG CONSOLIDATION 18 0.0064
217 MEGACOLON 10 0.0064
218 CLOSTRIDIUM TEST POSITIVE 14 0.0063
219 CARDIAC VALVE VEGETATION 3 0.0062
220 CEREBRAL ARTERY STENOSIS 3 0.0061
221 KLEBSIELLA TEST POSITIVE 4 0.0061
222 ENDOCARDITIS STAPHYLOCOCCAL 3 0.0061
223 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 36 0.0061
224 FUNCTIONAL GASTROINTESTINAL DISORDER 21 0.0061
225 ILEAL PERFORATION 4 0.0060
226 EMPYEMA 12 0.0060
227 RHINOVIRUS INFECTION 23 0.0059
228 PNEUMONIA PSEUDOMONAL 9 0.0059
229 ACUTE INTERSTITIAL PNEUMONITIS 3 0.0057
230 HYPERLEUKOCYTOSIS 5 0.0056
231 VENOOCCLUSIVE DISEASE 14 0.0056
232 LIVER ABSCESS 18 0.0055
233 CELL DEATH 11 0.0055
234 CRYPTOCOCCOSIS 9 0.0055
235 EPSTEIN-BARR VIRAEMIA 6 0.0054
236 CYTOKINE RELEASE SYNDROME 107 0.0053
237 LEUKAEMIA RECURRENT 9 0.0053
238 TRANSPLANT FAILURE 13 0.0053
239 ENTERITIS INFECTIOUS 9 0.0053
240 VITH NERVE PARALYSIS 6 0.0053
241 NEPHROPATHY TOXIC 57 0.0051
242 CEREBRAL HAEMATOMA 17 0.0051
243 VIRAEMIA 7 0.0051
244 PERITONEAL HAEMORRHAGE 7 0.0050
245 BRAIN HERNIATION 15 0.0050
246 CYSTITIS HAEMORRHAGIC 20 0.0050
247 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0049
248 CAPILLARY LEAK SYNDROME 10 0.0048
249 HYPERTRANSAMINASAEMIA 33 0.0047
250 BK VIRUS INFECTION 16 0.0047
251 DRY GANGRENE 3 0.0047
252 SERUM SICKNESS 13 0.0047
253 CHORIORETINITIS 3 0.0047
254 EOSINOPHILIC PNEUMONIA ACUTE 4 0.0046
255 INTRA-ABDOMINAL HAEMORRHAGE 11 0.0046
256 INFECTIOUS PLEURAL EFFUSION 7 0.0046
257 STREPTOCOCCAL BACTERAEMIA 5 0.0046
258 MENINGITIS CRYPTOCOCCAL 8 0.0046
259 LUNG TRANSPLANT REJECTION 3 0.0045
260 EMBOLIC CEREBRAL INFARCTION 3 0.0045
261 PSEUDOMEMBRANOUS COLITIS 10 0.0045
262 FUNGAL SKIN INFECTION 18 0.0045
263 ABSCESS NECK 3 0.0044
264 KLEBSIELLA SEPSIS 5 0.0044
265 HISTOPLASMOSIS DISSEMINATED 7 0.0044
266 INTESTINAL INFARCTION 4 0.0044
267 MARROW HYPERPLASIA 3 0.0044
268 SEPTIC SHOCK 191 0.0044
269 CYTOKINE STORM 3 0.0044
270 BACTERAEMIA 52 0.0044
271 COMPUTERISED TOMOGRAM THORAX ABNORMAL 3 0.0044
272 TRANSPLANT REJECTION 35 0.0044
273 HYPERBILIRUBINAEMIA 45 0.0043
274 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 10 0.0043
275 CRANIAL NERVE DISORDER 3 0.0043
276 CYTOMEGALOVIRUS VIRAEMIA 19 0.0043
277 INTRAOCULAR PRESSURE TEST ABNORMAL 3 0.0043
278 MENINGITIS BACTERIAL 6 0.0042
279 SHOCK HAEMORRHAGIC 34 0.0042
280 CHRONIC GRAFT VERSUS HOST DISEASE 15 0.0042
281 WOUND DEHISCENCE 14 0.0041
282 FEBRILE NEUTROPENIA 272 0.0041
283 CYTOMEGALOVIRUS INFECTION 68 0.0041
284 APLASIA 8 0.0041
285 NEUROLOGICAL SYMPTOM 23 0.0040
286 TUMOUR LYSIS SYNDROME 35 0.0040
287 DISSEMINATED INTRAVASCULAR COAGULATION 56 0.0040
288 CATHETER SITE INFECTION 15 0.0040
289 ACUTE RESPIRATORY DISTRESS SYNDROME 70 0.0040
290 HYPOALBUMINAEMIA 30 0.0039
291 DRUG RESISTANCE 98 0.0038
292 LUNG ABSCESS 8 0.0038
293 BLOOD FIBRINOGEN INCREASED 3 0.0038
294 GASTROENTERITIS NOROVIRUS 5 0.0038
295 ADENOCARCINOMA OF COLON 7 0.0037
296 STRONGYLOIDIASIS 6 0.0037
297 ISCHAEMIC HEPATITIS 5 0.0036
298 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 4 0.0036
299 RESPIRATORY ACIDOSIS 14 0.0036
300 CEREBRAL VENOUS SINUS THROMBOSIS 3 0.0036
301 GASTROINTESTINAL TOXICITY 17 0.0035
302 CAROTID ARTERY THROMBOSIS 3 0.0035
303 ATYPICAL MYCOBACTERIAL INFECTION 5 0.0035
304 ACUTE LYMPHOCYTIC LEUKAEMIA 10 0.0035
305 INFECTION REACTIVATION 4 0.0035
306 PUPILS UNEQUAL 4 0.0035
307 BILIRUBIN CONJUGATED INCREASED 8 0.0034
308 ENTEROCUTANEOUS FISTULA 3 0.0034
309 PULSELESS ELECTRICAL ACTIVITY 14 0.0033
310 SUSPECTED OFF LABEL USE 15 0.0033
311 PNEUMOMEDIASTINUM 6 0.0033
312 ENTEROCOLITIS INFECTIOUS 3 0.0033
313 PLATELET TRANSFUSION 4 0.0031
314 RESPIRATORY ALKALOSIS 5 0.0031
315 CYTOMEGALOVIRUS COLITIS 7 0.0030
316 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 4 0.0030
317 FUNGAL INFECTION 101 0.0030
318 HYPOFIBRINOGENAEMIA 3 0.0030
319 HYPERCAPNIA 9 0.0030
320 SMALL INTESTINAL HAEMORRHAGE 6 0.0030
321 MUCOSAL INFLAMMATION 78 0.0030
322 GLYCOSURIA 4 0.0030
323 CONJUNCTIVAL OEDEMA 3 0.0029
324 MYCOBACTERIAL INFECTION 5 0.0029
325 RESPIRATORY FAILURE 211 0.0029
326 RASH MORBILLIFORM 8 0.0029
327 VASCULAR PSEUDOANEURYSM 5 0.0029
328 BLAST CELL COUNT INCREASED 3 0.0029
329 STAPHYLOCOCCUS TEST POSITIVE 6 0.0028
330 THROMBOTIC THROMBOCYTOPENIC PURPURA 10 0.0028
331 TRANSPLANT DYSFUNCTION 5 0.0028
332 HYPERPHOSPHATAEMIA 6 0.0028
333 ACUTE RESPIRATORY FAILURE 53 0.0028
334 HYDROCEPHALUS 15 0.0028
335 OLIGURIA 17 0.0027
336 ENDOCARDITIS 14 0.0027
337 ORGAN FAILURE 11 0.0027
338 ORAL DISORDER 20 0.0027
339 CYTOMEGALOVIRUS INFECTION REACTIVATION 12 0.0027
340 HISTIOCYTOSIS HAEMATOPHAGIC 8 0.0027
341 BACTERIAL TEST POSITIVE 6 0.0027
342 STEROID DIABETES 4 0.0027
343 MULTI-ORGAN FAILURE 46 0.0027
344 HAEMORRHAGIC TRANSFORMATION STROKE 4 0.0027
345 STAPHYLOCOCCAL SEPSIS 13 0.0026
346 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0026
347 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 13 0.0026
348 HYPERNATRAEMIA 13 0.0026
349 CEREBRAL VENTRICLE DILATATION 3 0.0026
350 HYPOGAMMAGLOBULINAEMIA 17 0.0026
351 MYELITIS 4 0.0026
352 PSEUDOMONAS INFECTION 22 0.0026
353 THROMBOTIC MICROANGIOPATHY 25 0.0026
354 ESCHERICHIA TEST POSITIVE 3 0.0025
355 METABOLIC ALKALOSIS 4 0.0025
356 HAEMODYNAMIC INSTABILITY 19 0.0025
357 ACIDOSIS 19 0.0025
358 DEVICE RELATED INFECTION 38 0.0025
359 MONOCYTE COUNT DECREASED 3 0.0025
360 PSYCHIATRIC SYMPTOM 18 0.0024
361 ESCHERICHIA INFECTION 20 0.0024
362 HYPERVOLAEMIA 12 0.0024
363 PULMONARY MASS 36 0.0024
364 VASCULITIS 28 0.0024
365 ACUTE MYELOID LEUKAEMIA 37 0.0024
366 URINARY TRACT INFECTION BACTERIAL 6 0.0024
367 HYPOXIA 83 0.0024
368 DRUG LEVEL BELOW THERAPEUTIC 13 0.0024
369 BLOOD CULTURE POSITIVE 7 0.0023
370 PULMONARY ALVEOLAR HAEMORRHAGE 13 0.0023
371 LARGE INTESTINE PERFORATION 16 0.0023
372 PULMONARY HAEMORRHAGE 18 0.0023
373 APLASTIC ANAEMIA 12 0.0023
374 RESPIRATORY SYNCYTIAL VIRUS INFECTION 20 0.0023
375 TORSADE DE POINTES 18 0.0023
376 SERUM FERRITIN INCREASED 12 0.0023
377 LIVER TRANSPLANT REJECTION 4 0.0022
378 MONOPARESIS 4 0.0022
379 ENCEPHALOPATHY 54 0.0022
380 PNEUMOCYSTIS JIROVECII PNEUMONIA 22 0.0022
381 SOFT TISSUE INFECTION 4 0.0022
382 ENCEPHALITIS 15 0.0022
383 PNEUMOPERITONEUM 4 0.0022
384 OTOTOXICITY 4 0.0022
385 HAEMOLYTIC URAEMIC SYNDROME 5 0.0022
386 LUNG INFILTRATION 19 0.0021
387 PANCYTOPENIA 120 0.0021
388 ENDOTRACHEAL INTUBATION 6 0.0021
389 SHOCK 49 0.0021
390 CYTOPENIA 26 0.0021
391 OESOPHAGITIS 23 0.0021
392 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 20 0.0021
393 LACUNAR INFARCTION 5 0.0021
394 DIABETES INSIPIDUS 5 0.0021
395 SUBARACHNOID HAEMORRHAGE 21 0.0021
396 GASTROINTESTINAL NECROSIS 6 0.0021
397 HAEMATOLOGICAL INFECTION 5 0.0020
398 HYPOPHOSPHATAEMIA 15 0.0020
399 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
400 GENE MUTATION 4 0.0020
401 LUNG INFECTION 31 0.0020
402 BRAIN OEDEMA 25 0.0020
403 NOCARDIOSIS 5 0.0020
404 HEPATOSPLENOMEGALY 5 0.0019
405 HYPERURICAEMIA 8 0.0019
406 COAGULOPATHY 32 0.0019
407 RESPIRATORY DISTRESS 52 0.0019
408 HYPOVOLAEMIC SHOCK 9 0.0019
409 MALNUTRITION 21 0.0019
410 MYCOBACTERIUM AVIUM COMPLEX INFECTION 5 0.0019
411 ACUTE LEUKAEMIA 3 0.0019
412 STAPHYLOCOCCAL INFECTION 61 0.0018
413 SEPSIS 206 0.0018
414 TACHYPNOEA 25 0.0018
415 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 100 0.0018
416 NOSOCOMIAL INFECTION 4 0.0018
417 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 4 0.0018
418 BLOOD BILIRUBIN INCREASED 49 0.0018
419 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 14 0.0018
420 HEPATORENAL SYNDROME 3 0.0018
421 RENAL TUBULAR DISORDER 5 0.0018
422 BONE MARROW FAILURE 36 0.0018
423 NEUROTOXICITY 31 0.0018
424 PLEURAL EFFUSION 107 0.0018
425 DRUG-INDUCED LIVER INJURY 55 0.0018
426 NEUROLOGICAL DECOMPENSATION 4 0.0017
427 EXTREMITY NECROSIS 3 0.0017
428 TOXIC EPIDERMAL NECROLYSIS 26 0.0017
429 PROCTALGIA 11 0.0017
430 HYPERTRIGLYCERIDAEMIA 10 0.0017
431 PAPULE 12 0.0017
432 HYPERCALCAEMIA 21 0.0017
433 CLOSTRIDIUM DIFFICILE COLITIS 18 0.0017
434 HEPATIC FAILURE 51 0.0017
435 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
436 MIXED LIVER INJURY 5 0.0017
437 ASPARTATE AMINOTRANSFERASE INCREASED 88 0.0017
438 ORGANISING PNEUMONIA 8 0.0016
439 MULTIPLE-DRUG RESISTANCE 5 0.0016
440 HYPOKALAEMIA 74 0.0016
441 STEM CELL TRANSPLANT 4 0.0016
442 EOSINOPHILIA 28 0.0016
443 HEPATIC NECROSIS 6 0.0016
444 ABDOMINAL ABSCESS 7 0.0016
445 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 8 0.0016
446 PNEUMONIA VIRAL 5 0.0016
447 PHYSICAL DECONDITIONING 4 0.0016
448 ATELECTASIS 15 0.0016
449 FAILURE TO THRIVE 8 0.0015
450 RENAL TUBULAR NECROSIS 15 0.0015
451 POLYDIPSIA 6 0.0015
452 LUNG OPACITY 4 0.0015
453 NEUTROPENIA 206 0.0015
454 ALANINE AMINOTRANSFERASE INCREASED 91 0.0015
455 ACUTE KIDNEY INJURY 225 0.0015
456 BLOOD PHOSPHORUS INCREASED 4 0.0015
457 PLEURITIC PAIN 4 0.0014
458 HEPATOTOXICITY 32 0.0014
459 LEUKOCYTOSIS 26 0.0014
460 THROMBOPHLEBITIS 5 0.0014
461 FEBRILE BONE MARROW APLASIA 6 0.0014
462 CD4 LYMPHOCYTES DECREASED 3 0.0014
463 ABSCESS INTESTINAL 3 0.0014
464 PNEUMOTHORAX 22 0.0014
465 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
466 TOXIC ENCEPHALOPATHY 7 0.0014
467 TRANSAMINASES INCREASED 30 0.0013
468 RASH MACULO-PAPULAR 30 0.0013
469 MENINGITIS 9 0.0013
470 ILEUS PARALYTIC 6 0.0013
471 TONSILLITIS 7 0.0013
472 BACTERIAL INFECTION 25 0.0013
473 PANCREATITIS ACUTE 30 0.0013
474 METABOLIC ENCEPHALOPATHY 4 0.0013
475 DISTRIBUTIVE SHOCK 3 0.0013
476 BLOOD LOSS ANAEMIA 3 0.0013
477 LEUKOPENIA 66 0.0013
478 DRUG LEVEL ABOVE THERAPEUTIC 6 0.0013
479 PNEUMONIA BACTERIAL 12 0.0013
480 FLUID OVERLOAD 19 0.0013
481 STEVENS-JOHNSON SYNDROME 29 0.0013
482 BRUXISM 7 0.0013
483 METHAEMOGLOBINAEMIA 3 0.0013
484 BRAIN DEATH 4 0.0013
485 APPENDICITIS 12 0.0013
486 FAECALOMA 7 0.0013
487 BLOOD CREATININE DECREASED 4 0.0013
488 HAEMORRHAGE INTRACRANIAL 19 0.0013
489 COVID-19 PNEUMONIA 15 0.0013
490 STREPTOCOCCAL INFECTION 7 0.0013
491 MYELOSUPPRESSION 45 0.0012
492 CANDIDIASIS 5 0.0012
493 TRIGEMINAL NEURALGIA 5 0.0012
494 DERMATITIS BULLOUS 9 0.0012
495 BRONCHITIS CHRONIC 3 0.0012
496 HEPARIN-INDUCED THROMBOCYTOPENIA 6 0.0012
497 PERICARDIAL EFFUSION 28 0.0012
498 INFLAMMATORY MARKER INCREASED 6 0.0012
499 PERITONITIS 25 0.0012
500 METABOLIC DISORDER 7 0.0012
501 HEPATIC ENZYME ABNORMAL 6 0.0012
502 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
503 MENTAL STATUS CHANGES 33 0.0012
504 PRODUCT USE IN UNAPPROVED INDICATION 294 0.0012
505 POSTOPERATIVE WOUND INFECTION 8 0.0012
506 APPENDICITIS PERFORATED 3 0.0012
507 DRUG LEVEL DECREASED 12 0.0012
508 RENAL IMPAIRMENT 99 0.0012
509 ABDOMINAL INFECTION 3 0.0012
510 CENTRAL NERVOUS SYSTEM LESION 16 0.0012
511 ANURIA 10 0.0012
512 VENTRICULAR TACHYCARDIA 19 0.0011
513 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
514 CHOLESTASIS 22 0.0011
515 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
516 BLOOD ALBUMIN DECREASED 9 0.0011
517 ABSCESS 18 0.0011
518 TUBULOINTERSTITIAL NEPHRITIS 21 0.0011
519 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
520 NEUTROPENIC SEPSIS 8 0.0011
521 BLOOD PHOSPHORUS DECREASED 4 0.0011
522 TOXIC SKIN ERUPTION 11 0.0011
523 THROMBOCYTOSIS 4 0.0011
524 INTESTINAL ISCHAEMIA 6 0.0011
525 MACULE 3 0.0011
526 HYPOMAGNESAEMIA 15 0.0011
527 LIVER FUNCTION TEST INCREASED 23 0.0011
528 METABOLIC ACIDOSIS 34 0.0011
529 SMALL INTESTINAL OBSTRUCTION 13 0.0011
530 HEPATIC FUNCTION ABNORMAL 39 0.0010
531 OESOPHAGEAL ULCER 4 0.0010
532 COLITIS 39 0.0010
533 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
534 HAEMORRHAGIC STROKE 8 0.0010
535 CEREBRAL INFARCTION 25 0.0010
536 LYMPHOPROLIFERATIVE DISORDER 3 0.0010
537 VENOUS THROMBOSIS 4 0.0010
538 BLOOD ALKALINE PHOSPHATASE INCREASED 25 0.0010
539 OESOPHAGEAL CANDIDIASIS 4 0.0010
540 ATRIAL FLUTTER 8 0.0010
541 AZOTAEMIA 4 0.0010
542 MIOSIS 8 0.0010
543 DYSPHORIA 5 0.0010
544 DUODENITIS 3 0.0010
545 INTRACARDIAC THROMBUS 3 0.0010
546 POLYURIA 8 0.0010
547 UROSEPSIS 9 0.0010
548 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
549 CEREBRAL ISCHAEMIA 5 0.0010
550 AGRANULOCYTOSIS 18 0.0010
551 NEPHROPATHY 9 0.0010
552 RASH PUSTULAR 7 0.0010
553 DRUG ERUPTION 17 0.0010
554 MALABSORPTION 5 0.0010
555 THERAPY NON-RESPONDER 43 0.0010
556 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
557 ELECTROLYTE IMBALANCE 11 0.0009
558 CIRCULATORY COLLAPSE 16 0.0009
559 CUSHINGOID 3 0.0009
560 HAEMOPTYSIS 26 0.0009
561 THROMBOCYTOPENIA 104 0.0009
562 BLOOD MAGNESIUM DECREASED 8 0.0009
563 LACTIC ACIDOSIS 30 0.0009
564 HEPATIC LESION 4 0.0009
565 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 5 0.0009
566 LYMPHOCYTE COUNT DECREASED 16 0.0009
567 DISEASE PROGRESSION 107 0.0009
568 CYSTIC FIBROSIS 5 0.0009
569 CARDIAC FAILURE ACUTE 6 0.0009
570 SKIN MASS 6 0.0009
571 NECROSIS 5 0.0009
572 CARDIAC ARREST 74 0.0009
573 RENAL FAILURE 119 0.0009
574 UNRESPONSIVE TO STIMULI 23 0.0009
575 BRONCHIECTASIS 6 0.0009
576 IRON DEFICIENCY 4 0.0009
577 BLOOD CALCIUM DECREASED 10 0.0009
578 CLOSTRIDIAL INFECTION 3 0.0009
579 ASCITES 26 0.0009
580 HEPATIC CYST 3 0.0009
581 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
582 PYREXIA 302 0.0009
583 LIVER INJURY 21 0.0009
584 BRONCHIOLITIS 3 0.0009
585 NECROTISING FASCIITIS 3 0.0009
586 DRUG INTERACTION 135 0.0009
587 PULMONARY TOXICITY 6 0.0008
588 SPINAL COMPRESSION FRACTURE 7 0.0008
589 DRUG LEVEL INCREASED 14 0.0008
590 FIBRIN D DIMER INCREASED 3 0.0008
591 SUBDURAL HAEMATOMA 12 0.0008
592 ORAL CANDIDIASIS 11 0.0008
593 NERVOUS SYSTEM DISORDER 26 0.0008
594 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
595 TREATMENT FAILURE 68 0.0008
596 HEPATOMEGALY 8 0.0008
597 PNEUMONITIS 22 0.0008
598 GENERALISED OEDEMA 10 0.0008
599 ELECTROCARDIOGRAM QT PROLONGED 29 0.0008
600 CARDIAC DYSFUNCTION 3 0.0008
601 ABDOMINAL TENDERNESS 4 0.0008
602 DRUG INEFFECTIVE 1061 0.0008
603 ACUTE HEPATIC FAILURE 11 0.0008
604 ILEUS 10 0.0008
605 HYPERAMMONAEMIA 4 0.0008
606 DERMATITIS EXFOLIATIVE 4 0.0008
607 IMMUNOSUPPRESSION 7 0.0008
608 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
609 CARDIOTOXICITY 7 0.0008
610 LIPASE INCREASED 6 0.0008
611 CEREBRAL HAEMORRHAGE 28 0.0008
612 PHLEBITIS 4 0.0008
613 LYMPHOPENIA 11 0.0008
614 CACHEXIA 4 0.0008
615 OSTEOMYELITIS 14 0.0008
616 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 18 0.0008
617 HERPES SIMPLEX 5 0.0008
618 PETECHIAE 8 0.0008
619 GASTROINTESTINAL INFLAMMATION 6 0.0008
620 MYELODYSPLASTIC SYNDROME 11 0.0008
621 BLOOD LACTIC ACID INCREASED 4 0.0008
622 WALKING AID USER 5 0.0008
623 CORONAVIRUS INFECTION 5 0.0008
624 HYPERLIPIDAEMIA 9 0.0008
625 CEREBRAL ATROPHY 3 0.0008
626 ANAL ABSCESS 4 0.0007
627 GINGIVITIS 4 0.0007
628 INFECTION 107 0.0007
629 ALTERED STATE OF CONSCIOUSNESS 16 0.0007
630 NEUTROPHIL COUNT DECREASED 30 0.0007
631 ASPIRATION 8 0.0007
632 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
633 BLOOD UREA INCREASED 12 0.0007
634 HAEMATOCRIT DECREASED 14 0.0007
635 BLOOD CREATININE INCREASED 46 0.0007
636 FACIAL PARALYSIS 6 0.0007
637 NEUTROPHILIA 4 0.0007
638 LUNG NEOPLASM 3 0.0007
639 OFF LABEL USE 613 0.0007
640 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 18 0.0007
641 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
642 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
643 BLOOD URIC ACID INCREASED 4 0.0007
644 HYPOTHERMIA 7 0.0007
645 HYPOVOLAEMIA 4 0.0007
646 SPLENOMEGALY 8 0.0007
647 MOUTH HAEMORRHAGE 5 0.0007
648 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
649 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
650 PROTHROMBIN TIME PROLONGED 4 0.0007
651 RENAL FAILURE ACUTE 28 0.0007
652 HYPOGLYCAEMIA 32 0.0007
653 ADRENAL INSUFFICIENCY 8 0.0007
654 ISCHAEMIA 3 0.0007
655 HAEMOLYSIS 5 0.0006
656 MULTIPLE MYELOMA 3 0.0006
657 HYPOTENSION 129 0.0006
658 HAEMATURIA 22 0.0006
659 HYPOCALCAEMIA 12 0.0006
660 VENTRICULAR FIBRILLATION 7 0.0006
661 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
662 PNEUMONIA 200 0.0006
663 BLOOD POTASSIUM INCREASED 10 0.0006
664 COMA 29 0.0006
665 TACHYCARDIA 54 0.0006
666 C-REACTIVE PROTEIN INCREASED 22 0.0006
667 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
668 EMBOLISM 5 0.0006
669 EOSINOPHIL COUNT INCREASED 5 0.0006
670 HYPERKALAEMIA 21 0.0006
671 GASTROINTESTINAL HAEMORRHAGE 50 0.0006
672 HEMIPARESIS 10 0.0006
673 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
674 ECCHYMOSIS 4 0.0006
675 CONDITION AGGRAVATED 177 0.0006
676 PULMONARY OEDEMA 26 0.0006
677 EJECTION FRACTION DECREASED 9 0.0006
678 STOMATITIS 35 0.0006
679 NO THERAPEUTIC RESPONSE 7 0.0006
680 CYANOSIS 9 0.0006
681 HYPONATRAEMIA 32 0.0006
682 PANCREATITIS 30 0.0006
683 RASH ERYTHEMATOUS 27 0.0006
684 ANAL FISTULA 3 0.0006
685 PARALYSIS 8 0.0006
686 CARDIOGENIC SHOCK 8 0.0006
687 MYOSITIS 5 0.0006
688 PLATELET COUNT DECREASED 59 0.0006
689 MELAENA 12 0.0005
690 HEPATIC ENZYME INCREASED 37 0.0005
691 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
692 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
693 PLASMA CELL MYELOMA 21 0.0005
694 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
695 INTESTINAL PERFORATION 6 0.0005
696 ACUTE PULMONARY OEDEMA 3 0.0005
697 ATRIAL FIBRILLATION 52 0.0005
698 CYSTITIS 17 0.0005
699 ANAEMIA 101 0.0005
700 HYPERTHERMIA 4 0.0005
701 HYPERGLYCAEMIA 19 0.0005
702 ENTEROCOLITIS 3 0.0005
703 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
704 INTERSTITIAL LUNG DISEASE 25 0.0005
705 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
706 ISCHAEMIC STROKE 9 0.0005
707 ENDOPHTHALMITIS 3 0.0005
708 OXYGEN SATURATION DECREASED 28 0.0005
709 DIALYSIS 7 0.0005
710 SINUS TACHYCARDIA 7 0.0005
711 DECUBITUS ULCER 4 0.0005
712 CARDIOMEGALY 6 0.0005
713 CHOLANGITIS 3 0.0005
714 VENTRICULAR EXTRASYSTOLES 5 0.0005
715 PNEUMONIA ASPIRATION 12 0.0005
716 LYMPHADENOPATHY 17 0.0005
717 RESPIRATORY ARREST 13 0.0005
718 IMMUNODEFICIENCY 7 0.0005
719 HYPOPHAGIA 12 0.0005
720 ENTERITIS 3 0.0005
721 HAEMOGLOBIN ABNORMAL 3 0.0005
722 NAIL DISORDER 4 0.0005
723 THERAPY PARTIAL RESPONDER 7 0.0004
724 REBOUND EFFECT 5 0.0004
725 HIDRADENITIS 4 0.0004
726 CELLULITIS 22 0.0004
727 MYOCARDITIS 5 0.0004
728 APHASIA 13 0.0004
729 MOUTH ULCERATION 9 0.0004
730 ABDOMINAL PAIN 99 0.0004
731 DUODENAL ULCER 3 0.0004
732 HEPATOCELLULAR INJURY 6 0.0004
733 DISEASE RECURRENCE 20 0.0004
734 CHOLECYSTITIS 5 0.0004
735 MYOCLONUS 5 0.0004
736 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
737 PRODUCT PRESCRIBING ISSUE 9 0.0004
738 PRESYNCOPE 10 0.0004
739 LIVER DISORDER 18 0.0004
740 RESPIRATORY DISORDER 12 0.0004
741 SKIN LESION 11 0.0004
742 HYDRONEPHROSIS 3 0.0004
743 WHITE BLOOD CELL COUNT DECREASED 43 0.0004
744 EYELID PTOSIS 4 0.0004
745 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
746 CARDIAC FAILURE 31 0.0004
747 PULMONARY HYPERTENSION 8 0.0004
748 HERPES ZOSTER 22 0.0004
749 CARDIO-RESPIRATORY ARREST 16 0.0004
750 PULMONARY CONGESTION 5 0.0004
751 PALLOR 10 0.0004
752 HICCUPS 3 0.0004
753 PHOTOSENSITIVITY REACTION 6 0.0004
754 ACUTE CORONARY SYNDROME 3 0.0004
755 PRESCRIBED OVERDOSE 7 0.0004
756 EPILEPSY 11 0.0004
757 URINARY RETENTION 12 0.0004
758 BRADYCARDIA 19 0.0004
759 HAEMATEMESIS 9 0.0004
760 CHROMATURIA 8 0.0004
761 GENERAL PHYSICAL HEALTH DETERIORATION 41 0.0004
762 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
763 HEPATITIS 9 0.0004
764 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
765 RED BLOOD CELL COUNT DECREASED 10 0.0003
766 INFUSION RELATED REACTION 23 0.0003
767 HAEMATOCHEZIA 19 0.0003
768 RENAL DISORDER 16 0.0003
769 BLOOD CALCIUM INCREASED 3 0.0003
770 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
771 HAEMOGLOBIN DECREASED 35 0.0003
772 CARDIOMYOPATHY 5 0.0003
773 ARRHYTHMIA 16 0.0003
774 RENAL INJURY 10 0.0003
775 HYPERTENSION 71 0.0003
776 HAEMOLYTIC ANAEMIA 3 0.0003
777 BLOOD POTASSIUM DECREASED 10 0.0003
778 SEIZURE 38 0.0003
779 END STAGE RENAL DISEASE 6 0.0003
780 RESTLESSNESS 12 0.0003
781 HEPATIC ENCEPHALOPATHY 3 0.0003
782 FLANK PAIN 3 0.0003
783 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
784 ORAL PAIN 7 0.0003
785 SINUSITIS 32 0.0003
786 TOXICITY TO VARIOUS AGENTS 52 0.0003
787 RESPIRATORY TRACT INFECTION 8 0.0003
788 INFLAMMATORY BOWEL DISEASE 3 0.0003
789 IMMUNE SYSTEM DISORDER 4 0.0003
790 RECTAL HAEMORRHAGE 13 0.0003
791 PERICARDITIS 5 0.0003
792 GINGIVAL BLEEDING 4 0.0003
793 DIVERTICULITIS 8 0.0003
794 NEOPLASM PROGRESSION 10 0.0003
795 DERMATITIS 6 0.0003
796 BRONCHOSPASM 4 0.0003
797 DIARRHOEA 174 0.0003
798 ABDOMINAL DISTENSION 28 0.0003
799 GASTRITIS 7 0.0003
800 DYSARTHRIA 10 0.0003
801 BLOOD COUNT ABNORMAL 4 0.0003
802 RHABDOMYOLYSIS 11 0.0003
803 MALIGNANT NEOPLASM PROGRESSION 27 0.0003
804 GASTRIC ULCER 5 0.0003
805 GASTRIC HAEMORRHAGE 3 0.0003
806 POST PROCEDURAL COMPLICATION 5 0.0003
807 JAUNDICE 7 0.0003
808 METASTASES TO LUNG 3 0.0003
809 DELIRIUM 9 0.0003
810 LYMPHOMA 4 0.0003
811 BONE PAIN 15 0.0003
812 CHILLS 30 0.0003
813 EPISTAXIS 19 0.0003
814 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 18 0.0003
815 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
816 FULL BLOOD COUNT DECREASED 5 0.0002
817 LUNG DISORDER 12 0.0002
818 PRODUCT USE ISSUE 46 0.0002
819 IMPAIRED HEALING 8 0.0002
820 HAEMORRHAGE 25 0.0002
821 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
822 ACUTE MYOCARDIAL INFARCTION 7 0.0002
823 FACE OEDEMA 4 0.0002
824 HALLUCINATION, VISUAL 5 0.0002
825 MUSCLE ATROPHY 3 0.0002
826 INTRAOCULAR PRESSURE INCREASED 3 0.0002
827 METRORRHAGIA 4 0.0002
828 ANAPHYLACTIC SHOCK 6 0.0002
829 INFLAMMATION 12 0.0002
830 SKIN ULCER 6 0.0002
831 VOMITING 109 0.0002
832 HAEMATOMA 6 0.0002
833 PRODUCTIVE COUGH 11 0.0002
834 DYSKINESIA 9 0.0002
835 ANAPHYLACTIC REACTION 12 0.0002
836 MASS 3 0.0002
837 PHOTOPHOBIA 4 0.0002
838 BLOOD PRESSURE DECREASED 14 0.0002
839 CHRONIC KIDNEY DISEASE 16 0.0002
840 PROTEINURIA 4 0.0002
841 LIVER FUNCTION TEST ABNORMAL 6 0.0002
842 GASTROENTERITIS 3 0.0002
843 LOSS OF CONSCIOUSNESS 26 0.0002
844 OEDEMA 11 0.0002
845 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
846 NEUROPATHY PERIPHERAL 19 0.0002
847 URINARY TRACT INFECTION 34 0.0002
848 OEDEMA PERIPHERAL 24 0.0002
849 DYSPNOEA 111 0.0002
850 BODY TEMPERATURE INCREASED 4 0.0002
851 COVID-19 34 0.0002
852 SWELLING 18 0.0002
853 DEAFNESS 5 0.0002
854 HYPOTHYROIDISM 6 0.0002
855 DEEP VEIN THROMBOSIS 12 0.0002
856 FAECES DISCOLOURED 4 0.0002
857 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
858 METASTASES TO BONE 3 0.0002
859 FLUID RETENTION 9 0.0002
860 LETHARGY 10 0.0002
861 METASTASES TO LIVER 3 0.0002
862 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
863 GASTROINTESTINAL DISORDER 15 0.0002
864 CONFUSIONAL STATE 27 0.0002
865 THERAPEUTIC RESPONSE DECREASED 10 0.0002
866 EXTRAPYRAMIDAL DISORDER 4 0.0002
867 HEPATIC STEATOSIS 3 0.0002
868 MENTAL DISORDER 7 0.0002
869 DYSPNOEA EXERTIONAL 6 0.0002
870 BLOOD SODIUM DECREASED 3 0.0002
871 RASH 69 0.0002
872 NAUSEA 125 0.0002
873 PULMONARY EMBOLISM 15 0.0002
874 DEHYDRATION 21 0.0002
875 DEATH 135 0.0002
876 CHOLELITHIASIS 5 0.0002
877 INFLUENZA 17 0.0002
878 DISORIENTATION 6 0.0002
879 BLISTER 8 0.0001
880 EATING DISORDER 3 0.0001
881 SYNCOPE 14 0.0001
882 TREMOR 23 0.0001
883 DYSPHAGIA 13 0.0001
884 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
885 LABORATORY TEST ABNORMAL 4 0.0001
886 COUGH 38 0.0001
887 URINARY INCONTINENCE 4 0.0001
888 DRUG INTOLERANCE 13 0.0001
889 DECREASED APPETITE 31 0.0001
890 CONSTIPATION 29 0.0001
891 HEART RATE IRREGULAR 3 0.0001
892 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
893 SKIN EXFOLIATION 11 0.0001
894 RASH PRURITIC 7 0.0001
895 WEIGHT DECREASED 35 0.0001
896 BLOOD PRESSURE FLUCTUATION 3 0.0001
897 DIABETIC KETOACIDOSIS 3 0.0001
898 CHEST PAIN 23 0.0001
899 MENTAL IMPAIRMENT 3 0.0001
900 BLINDNESS 5 0.0001
901 CONVULSION 7 0.0001
902 VIRAL INFECTION 4 0.0001
903 PALPITATIONS 14 0.0001
904 HALLUCINATION 9 0.0001
905 OROPHARYNGEAL PAIN 11 0.0001
906 ABDOMINAL PAIN LOWER 3 0.0001
907 BACK PAIN 27 0.0001
908 MUSCULAR WEAKNESS 13 0.0001
909 INTENTIONAL PRODUCT MISUSE 10 0.0001
910 ANGIOEDEMA 5 0.0001
911 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
912 VISION BLURRED 15 0.0001
913 TINNITUS 5 0.0001
914 SKIN DISCOLOURATION 5 0.0001
915 DYSURIA 4 0.0001
916 CHEST DISCOMFORT 11 0.0001
917 INTESTINAL OBSTRUCTION 4 0.0001
918 NO ADVERSE EVENT 19 0.0001
919 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
920 CARDIAC FAILURE CONGESTIVE 8 0.0001
921 SLEEP DISORDER 7 0.0001
922 VISUAL IMPAIRMENT 12 0.0001
923 UNDERDOSE 7 0.0001
924 MUSCULOSKELETAL PAIN 5 0.0001
925 BRONCHITIS 7 0.0001
926 MOOD SWINGS 3 0.0001
927 SWELLING FACE 6 0.0001
928 TREATMENT NONCOMPLIANCE 5 0.0001
929 ABDOMINAL PAIN UPPER 18 0.0001
930 THROMBOSIS 7 0.0001
931 DYSPHONIA 5 0.0001
932 WEIGHT INCREASED 19 0.0001
933 HEADACHE 53 0.0001
934 DRUG EFFECT INCOMPLETE 3 0.0001
935 ILL-DEFINED DISORDER 5 0.0001
936 AGITATION 6 0.0001
937 HYPERSENSITIVITY 15 0.0001
938 EXPOSURE DURING PREGNANCY 5 0.0001
939 ASTHENIA 30 0.0001
940 BLOOD GLUCOSE INCREASED 15 0.0001
941 SOMNOLENCE 16 0.0001
942 THERAPY CESSATION 4 0.0001
943 RHINORRHOEA 5 0.0001
944 CEREBROVASCULAR ACCIDENT 13 0.0001
945 ECZEMA 4 0.0001
946 SPEECH DISORDER 4 0.0001
947 PAIN IN EXTREMITY 22 0.0001
948 HOSPITALISATION 11 0.0001
949 NECK PAIN 4 0.0001
950 EYE PAIN 4 0.0001
951 PAIN 43 0.0001
952 BALANCE DISORDER 6 0.0001
953 ERYTHEMA 14 0.0001
954 WHEEZING 4 0.0001
955 ADVERSE EVENT 6 0.0001
956 OVERDOSE 14 0.0001
957 MYALGIA 11 0.0001
958 INSOMNIA 17 0.0001
959 GAIT DISTURBANCE 12 0.0001
960 PERIPHERAL SWELLING 9 0.0001
961 DEVICE MALFUNCTION 4 0.0001
962 FATIGUE 44 0.0001
963 MUSCLE SPASMS 10 0.0001
964 FALL 18 0.0001
965 NASAL CONGESTION 3 0.0001
966 PARAESTHESIA 8 0.0001
967 DIZZINESS 25 0.0001
968 ILLNESS 5 0.0000
969 HYPERHIDROSIS 6 0.0000
970 ARTHRALGIA 19 0.0000
971 MALAISE 18 0.0000
972 HEART RATE INCREASED 4 0.0000
973 DIABETES MELLITUS 3 0.0000
974 BLOOD PRESSURE INCREASED 6 0.0000
975 ABDOMINAL DISCOMFORT 6 0.0000
976 ALOPECIA 7 0.0000
977 ASTHMA 4 0.0000
978 ANXIETY 10 0.0000
979 MYOCARDIAL INFARCTION 6 0.0000
980 MUSCULOSKELETAL STIFFNESS 3 0.0000
981 DRUG WITHDRAWAL SYNDROME 3 0.0000
982 PRURITUS 13 0.0000
983 ADVERSE DRUG REACTION 3 0.0000
984 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
985 JOINT SWELLING 4 0.0000
986 CARDIAC DISORDER 3 0.0000
987 CONTUSION 3 0.0000
988 DYSPEPSIA 3 0.0000
989 URTICARIA 5 0.0000
990 HYPOAESTHESIA 4 0.0000
991 PRODUCT DOSE OMISSION ISSUE 7 0.0000
992 DEPRESSION 5 0.0000
993 INCORRECT DOSE ADMINISTERED 5 0.0000
994 NASOPHARYNGITIS 4 0.0000
995 DRUG DOSE OMISSION 3 0.0000
996 INJECTION SITE PAIN 3 0.0000